title: Type 1 diabetes mellitus caused by treatment with interferon-beta.
abstract: A 57-year-old man was referred to our outpatient clinic after interferon-beta (IFN-beta) treatment for 7 weeks. While IFN-beta therapy was continued in our outpatient clinic, his blood glucose level increased gradually, and he was admitted to our hospital for hyperglycemia. The patient was prescribed a 1,600-kcal diet and intensive insulin therapy was performed. GAD antibody became positive 15 months after the start of IFN therapy, and disappeared 27 months after the start of IFN therapy. Insulin secretion was depleted and the patient had HLA-DR4, B54, and DRB1*0405. This appears to be a case of type 1 diabetes mellitus induced by administration of IFN-beta alone.
authors.affiliation: Department of Internal Medicine 5, Tokyo Medical University, Ami, Ibaragi.
authors.forename: S
authors.initials: S
authors.lastname: Kado
authors.forename: J
authors.initials: J
authors.lastname: Miyamoto
authors.forename: N
authors.initials: N
authors.lastname: Komatsu
authors.forename: Y
authors.initials: Y
authors.lastname: Iwaki
authors.forename: H
authors.initials: H
authors.lastname: Ozaki
authors.forename: H
authors.initials: H
authors.lastname: Taguchi
authors.forename: M
authors.initials: M
authors.lastname: Kure
authors.forename: G
authors.initials: G
authors.lastname: Sarashina
authors.forename: T
authors.initials: T
authors.lastname: Watanabe
authors.forename: Y
authors.initials: Y
authors.lastname: Katsura
authors.forename: Y
authors.initials: Y
authors.lastname: Nemoto
authors.forename: M
authors.initials: M
authors.lastname: Noritake
authors.forename: T
authors.initials: T
authors.lastname: Matsuoka
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D001706:Biopsy; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D016899:Interferon-beta / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
chemical_list: D000998:Antiviral Agents; D007004:Hypoglycemic Agents; D007328:Insulin; D016899:Interferon-beta